Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
GTHP GUIDED THERAPEUTICS INC
0.235-0.055-18.97%
Trading Session
02/02 11:25 ET
High
0.277
Open
0.240
Turnover
8.31K
Low
0.235
Pre Close
0.290
Volume
34.75K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
Guided Therapeutics, Inc. or the "Company" (OTCQB:GTHP), the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company's patented biophotonic technology, announced today it had executed
Guided Therapeutics gets IRB approval for LuViva Advanced Cervical Scan trial
Guided Therapeutics announced that it has obtained Institutional Review Board, or IRB, approval to initiate its clinical trial aimed at obtaining FDA approval for the company's LuViva Advanced Cervica
Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan
Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced that it has obtained Institutional Review Board (IRB) approval to initiate i
No More
Company Overview
More
Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. It also focuses on the selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The company was founded by Shabbir Bakir Bambot and Mark L. Faupel on October 27, 1992 and is headquartered in Norcross, GA.
CEO： Dr. Gene Cartwright, PhD
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet